Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 1:25 pm Purchase | 2024-12-31 | 13G | AVENUE THERAPEUTICS INC PA ATXI | Ikarian Capital, LLC | 140,000 6.800% | 140,000 (New Position) | Filing History |
| 2025-02-14 1:22 pm Purchase | 2024-12-31 | 13G | GALERA THERAPEUTICS INC GRTX | Ikarian Capital, LLC | 37,693 9.990% | 37,693 (New Position) | Filing History |
| 2025-02-14 1:21 pm Purchase | 2024-12-31 | 13G | AETHLON MED INC PAR $0.001 AEMD | Ikarian Capital, LLC | 3,073 8.700% | 3,073 (New Position) | Filing History |
| 2025-02-14 1:18 pm Purchase | 2024-12-31 | 13G | TRAWS PHARMA, INC PAR TRAW | Ikarian Capital, LLC | 394,255 9.990% | 394,255 (New Position) | Filing History |
| 2025-02-14 1:15 pm Purchase | 2024-12-31 | 13G | FORTE BIOSCIENCES INC FBRX | Ikarian Capital, LLC | 609,225 9.500% | 609,225 (New Position) | Filing History |
| 2025-02-14 1:09 pm Purchase | 2024-12-31 | 13G | CHANNEL THERAPEUTICS CORPORATI CHRO | Ikarian Capital, LLC | 44,085 7.300% | 44,085 (New Position) | Filing History |
| 2025-02-14 1:07 pm Purchase | 2024-12-31 | 13G | ALPHA COGNITION INC NE ACOG | Ikarian Capital, LLC | 967,867 6.000% | 967,867 (New Position) | Filing History |
| 2024-11-14 8:51 pm Sale | 2024-09-30 | 13G | TRACON PHARMACEUTICALS INC TCON | Ikarian Capital, LLC | 133,404 3.900% | -143 (-0.11%) | Filing History |
| 2024-11-14 8:47 pm Purchase | 2024-09-30 | 13G | IBIO INC PAR $0.001 IBIO | Ikarian Capital, LLC | 599,913 6.600% | 599,913 (New Position) | Filing History |
| 2024-10-07 8:06 pm Purchase | 2024-09-30 | 13G | AVALO THERAPEUTICS INC PAR AVTX | Ikarian Capital, LLC | 970,359 10.020% | 970,359 (New Position) | Filing History |
| 2024-04-05 4:10 pm Sale | 2024-03-31 | 13G | TRACON PHARMACEUTICALS INC TCON | Ikarian Capital, LLC | 133,547 5.900% | -4,730 (-3.42%) | Filing History |
| 2024-02-14 6:00 pm Unchanged | 2023-12-31 | 13G | BELLICUM PHARMACEUTICALS INC C BLCM | Ikarian Capital, LLC | 448,101 4.600% | 0 (Unchanged) | Filing History |
| 2023-02-14 12:57 pm Purchase | 2022-12-31 | 13G | TRACON PHARMACEUTICALS INC TCON | Ikarian Capital, LLC | 138,277 12.500% | 120,820 (+692.10%) | Filing History |
| 2023-02-14 11:26 am Sale | 2022-12-31 | 13G | X4 PHARMACEUTICALS INC XFOR | Ikarian Capital, LLC | 11,638 0.300% | -63,845 (-84.58%) | Filing History |
| 2023-02-14 11:03 am Sale | 2022-12-31 | 13G | MILESTONE PHARMACEUTICALS INC MIST | Ikarian Capital, LLC | 460,416 1.300% | -1,289,627 (-73.69%) | Filing History |
| 2023-02-14 11:02 am Sale | 2022-12-31 | 13G | BELLICUM PHARMACEUTICALS INC C BLCM | Ikarian Capital, LLC | 448,101 5.200% | -48,655 (-9.79%) | Filing History |
| 2022-02-14 4:43 pm Sale | 2021-12-31 | 13G | X4 PHARMACEUTICALS INC XFOR | Ikarian Capital, LLC | 75,483 8.100% | -14,221 (-15.85%) | Filing History |
| 2022-02-14 4:41 pm Sale | 2021-12-31 | 13G | ATYR PHARMA INC ATYR | Ikarian Capital, LLC | 35,048 0.100% | -853,532 (-96.06%) | Filing History |
| 2022-02-14 4:39 pm Sale | 2021-12-31 | 13G | PROTARA THERAPEUTICS INC TARA | Ikarian Capital, LLC | 279,256 2.500% | -370,286 (-57.01%) | Filing History |
| 2022-02-14 4:37 pm Purchase | 2021-12-31 | 13G | TRACON PHARMACEUTICALS INC TCON | Ikarian Capital, LLC | 134,556 13.800% | 89,488 (+198.56%) | Filing History |